These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32015090)

  • 1. Use of MRI to predict symptomatic haemorrhagic transformation after thrombolysis for cerebral ischaemia.
    Caparros F; Kuchcinski G; Drelon A; Casolla B; Moulin S; Dequatre-Ponchelle N; Henon H; Cordonnier C; Pruvo JP; Leys D
    J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):402-410. PubMed ID: 32015090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
    Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
    Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
    Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
    Jucevičiūtė N; Mikužis P; Balnytė R
    BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.
    Tanaka K; Matsumoto S; Furuta K; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Thromb Thrombolysis; 2020 Jul; 50(1):174-180. PubMed ID: 31745858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.
    Derex L; Hermier M; Adeleine P; Pialat JB; Wiart M; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P; Nighoghossian N
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):70-5. PubMed ID: 15607998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke.
    Zou M; Churilov L; He A; Campbell B; Davis SM; Yan B
    J Clin Neurosci; 2013 Jul; 20(7):984-7. PubMed ID: 23664409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
    Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K
    Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction.
    Wang R; Zeng J; Wang F; Zhuang X; Chen X; Miao J
    QJM; 2019 May; 112(5):323-326. PubMed ID: 30566606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia.
    Myslimi F; Caparros F; Dequatre-Ponchelle N; Moulin S; Gautier S; Girardie P; Cordonnier C; Bordet R; Leys D
    Stroke; 2016 Jul; 47(7):1825-30. PubMed ID: 27197851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A; Pasi M; Fiorelli M; Shams S; von Kummer R; Pantoni L; Rost N
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-PA: the SEDAN score.
    Brüning T; Al-Khaled M
    CNS Neurosci Ther; 2015 Mar; 21(3):296-7. PubMed ID: 25622691
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis.
    Kidwell CS; Saver JL; Carneado J; Sayre J; Starkman S; Duckwiler G; Gobin YP; Jahan R; Vespa P; Villablanca JP; Liebeskind DS; Vinuela F
    Stroke; 2002 Mar; 33(3):717-24. PubMed ID: 11872894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Non-Traditional Lipid Parameters with Hemorrhagic Transformation and Clinical Outcome After Thrombolysis in Ischemic Stroke Patients.
    Luo Y; Chen J; Yan XL; Jin H; Sun X; Guo ZN; Yang Y
    Curr Neurovasc Res; 2020; 17(5):736-744. PubMed ID: 33397260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
    Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J
    Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.